-
Mashup Score: 2Don't Miss a Beat: REBALANCE-HF, with Marat Fudim, MD, MHS - 6 month(s) ago
Hosts are joined by Marat Fudim, MD, MHS, of Duke, to discuss the REBALANCE-HF trial, which examined endovascular ablation of the right greater splanchnic nerve in heart failure with preserved ejection fraction.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Few Eligible for Surveillance Without Anticoagulation Among Those With Subsegmental Pulmonary Embolism - 8 month(s) ago
This new research indicates that while there are ongoing trials seeking to define which individuals with subsegmental PE may be surveilled, greater uptake of newer surveillance actions may necessitate more than passive diffusion.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Can IV ferric carboxymaltose improve outcomes in #HeartFailure? The community may get an answer at #ESCCongress2023. Learn more in our ESC preview episode #DontMissABeat with @SJGreene_md and @mvaduganathan: https://t.co/rxDI3umbCg https://t.co/mm9Y136lYL
-
-
Mashup Score: 3Don't Miss a Beat: ESC Congress 2023 Preview & SELECT Reaction - 8 month(s) ago
In this episode of Don’t Miss a Beat, hosts offer a breakdown of 3 trials of note from the upcoming ESC Congress 2023 and provide context around the recent announcement of topline results from the SELECT trial.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet-
Headed to #ESCcongress2023 or attending virtually? Learn what trials the experts are looking forward to in the latest episode of #DontMissABeat. In the preview below, @SJGreene_md and @MVaduganathan discuss the QUEST trial: https://t.co/jnU08OSDUn https://t.co/C9t6jR4vUr
-
-
Mashup Score: 1Don't Miss a Beat: ESC Heart Failure Association Preview - 11 month(s) ago
In this episode of Don’t Miss a Beat, hosts sit down at ESC HFA to discuss key takeaways from the ACC’s expert clinical decision pathway and preview HFpEF data scheduled to be presented during the meeting.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Catch up on the latest in #heartfailure management in the latest episode of #DontMissaBeat, which tackles a new expert consensus decision pathway for HFpEF and previews data from the ESC #HeartFailure2023 meeting. https://t.co/lHflnPHI0Y https://t.co/Z7T4GqcLHL
-
-
Mashup Score: 1Don't Miss a Beat: ESC Heart Failure Association Preview - 11 month(s) ago
In this episode of Don’t Miss a Beat, hosts sit down at ESC HFA to discuss key takeaways from the ACC’s expert clinical decision pathway and preview HFpEF data scheduled to be presented during the meeting.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Headed to #HeartFailure2023? Check out the latest episode of #DontMissABeat, where hosts @mvaduganathan and @SJGreene_md break down the recent @ACCinTouch ECDP in HFpEF and preview data from the upcoming ESC HFA meeting. https://t.co/lHflnPHI0Y https://t.co/1fnE4aMRzG
-
-
Mashup Score: 2FDA Expands Dapagliflozin Label to Include Reducing Risk of CV Death in Heart Failure - 12 month(s) ago
Announced just more than a year after AstraZeneca announced topline results, the FDA has approved a label expansion to include reducing cardiovascular death and HF hospitalizations for dapagliflozin based on results of the phase 3 DELIVER trial.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
The FDA has approved a label expansion for dapagliflozin to include reducing CV death and hospitalizations for HF in adults with #HeartFailure based on results from the DELIVER trial. In an episode of #DontMissABeat, @mvaduganathan broke down the trial: https://t.co/XJ7AnWoqPe https://t.co/Pm1Nx1Gxb5
-
-
Mashup Score: 0Don't Miss a Beat: Top Takeaways from NUDGE FLU at ACC 2023 - 1 year(s) ago
Hosts are joined by Tor Biering-Sørenson, MD, MSc, MPH, PhD, to discuss the NUDGE FLU trial and how the lessons learned can inform implementation strategies for various other types of therapies.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Interested in learning more about NUDGE FLU? Check out this special edition episode of #DontMissABeat from #ACC2023 with lead investigator Prof. Tor Biering-Sørenson: https://t.co/iFNvAu5t9Y #Cardiology #Influenza
-
-
Mashup Score: 0Don't Miss a Beat: STRONG-HF with Alexandre Mebazaa, MD, PhD - 1 year(s) ago
Don’t Miss a Beat hosts are joined by Alexandre Mebazaa, MD, PhD, lead investigator of the STRONG-HF trial, to discuss the inspiration for the trial, its design, and important takeaways for those looking to implement a similar strategy of rapid, in-hospital uptitration of GDMT in heart failure at their own practice.
Source: HCP LiveCategories: General Medicine News, Latest HeadlinesTweet-
Earlier this week, #DontMissABeat made its @HCPLiveCardio debut. Check out the discussion around STRONG-HF results with @AlexMebazaa https://t.co/IGB5eshpOy
-
-
Mashup Score: 0Don't Miss a Beat: oHCM and Mavacamten - 2 year(s) ago
Listen to this episode from Don’t Miss a Beat on Spotify. A first-in-class allosteric and reversible inhibitor selective for cardiac myosin approved based on the results of the EXPLORER-HCM trial, mavacamten was approved for the treatment of adults with symptomatic NYHA class 2-3 obstructive hypertrophic cardiomyopathy after their phase 3 data indicated use was with improved exercise capacity,…
Source: SpotifyCategories: Cardiologists, Latest HeadlinesTweet-
This month on #DontMissABeat, @mvaduganathan & I were honored to discuss #EXPLORER_HCM & #mavacamten w/ guest #HCM expert @tikuowens! ✅trial design &🔑results ✅#RCT endpoint considerations for #HCM ✅magnitude of KCCQ benefit ✅implementation https://t.co/PuT52ErjAq https://t.co/V1tGs4I8lP
-
-
Mashup Score: 2Don't Miss a Beat: Interpreting New Heart Failure Guidelines - 2 year(s) ago
Listen to this episode from Don’t Miss a Beat on Spotify. In this episode of Don’t Miss a Beat, hosts Drs. Greene and Vaduganathan break down the new ACC/AHA/HFSA heart failure guidelines debuted at ACC.22 and compare the recommendations against those made in the European Society of Cardiology’s 2021 heart failure guidelines.
Source: SpotifyCategories: Cardiologists, Latest HeadlinesTweet-
New episode of #DontMissABeat now up! This month, @mvaduganathan & I dive into the new US #HF guidelines w/ key takeaways for practice. ✅ #QuadTherapy ✅ #SGLT2i for HFmrEF, HFpEF ✅ ACC/AHA vs ESC ✅ #HFimpEF ✅ Value statements ✅ #HF prevention https://t.co/XpR1YiyIDZ https://t.co/3u9O0xb8j7
-
The video version of #DontMissABeat is now live! Check out this preview and use the link below to hear @FudimMarat breakdown REBALANCE-HF with @mvaduganathan and @SJGreene_md. https://t.co/mc4zPBe6T2 #HeartFailure #HFSA2023 https://t.co/ObQZt4E63T